IPTLD®

Insulin Potentiation Therapy was initially developed by my grandfather, Donato Pérez García, Sr. M.D. IPT targets the treatment of a cell by changing the bio-physio-chemical constants and parameters of the blood. This pathway initially attacks the cancerous cell itself through its intra-cellular environment and extra-cellular environment by permeabilizing the cell membrane via insulin.

IPT is a targeted therapy for cancer and chronic disease; the power of chemotherapy is directed only to cancer cells and not a patient’s entire body. In addition, the chemo is delivered at a fraction of the normal dose. This approach eliminates or significantly reduces the dreaded side-effects of conventional chemo. IPTLD annihilates cancer cells by employing the very same mechanisms that cancer cells utilize to kill people.

Friday, September 3, 2010

The opinion of the son in law of a cancer patients about the family experience of being treated in Tijuana by Dr. Donato Perez Garcia,MD. (September 2, 2010)

Comment by Donato Perez Garcia,MD

IPT or IPTLD is not a product that comes in a Box and the trained IPT doctor opens and mixes it to deliver.

IPTLD/IPT is a service provided by a talented, trained, educated and experienced, medical doctor that requires him/her to know the principles of pre treating your body with insulin and what it does and then to know the different chemo drugs, which ones can be combined and their possible side effects. Pre treating a patient with insulin helps to potentiate or enhance the effect of that chemo drug and this means that resistance is minimized.

The combination of chemo drugs I choose are based on several factors for each patient, age, sex, allergies, diet habits, exercise and activity history, among some and I choose the best ones that the pharmaceutical companies consider their best ones. Of course the amount I choose is considerably less than what the manufacturer recommends because I am using it in combination with the potentiating effect of insulin. If the patient has a cancer recurrence and is concerned with the combination that I will use I can tell you and assure you that during my more than 28 years of practicing IPTLD/IPT (something none of my IPT students worldwide have) I have seen that patients that were told they were resistant to XYZ chemotherapy drug they respond when used along with insulin. If the patient comes with tests -sensitivity- done on the tissue or the blood that reports which ones are effective, I take a look and have them as plan B, C, D, etc, because these tests are done for the standard chemotherapy dosages not for the IPTLD/IPT protocol; when these tests consider the chemical-physical changes insulin produces then the tests will definitely be more accurate to be used with IPT/IPTLD.

Back in the year 1980, R. North an immunologist from the Trudeau Institute in New York and colleagues were able to produce immune cycling with tumor regression by directing chemotherapy to immune suppressor cells. He also reported that if chemotherapy was given at the wrong day and earlier, it will not work, instead the tumor will grow faster and will give the impression that the tumor was resistant to the chemotherapy drug. (Science Magazine,May 2010)

While several of the IPT doctors that I have trained on Insulin Potentiation Therapy (IPT) and some patients who have a cancer recurrence are concerned with finding which chemotherapy drug will work best I tell them that to have a successful treatment of cancer depends on the accurate timing of delivering chemotherapy to match the fluctuation in each patient's immune system.

Not all cancer patients are cured by surgery, radiotherapy, biological therapies, alternative treatments, standard high dose chemotherapy or even low dose chemo. Some patients achieve a complete regression, others do not respond and others appear to have some level of clinical response.

Traditional cancer therapies affect some cancer cells but also normal cells and produce the well known side effects.

Today September 2010, my Insulin Potentiation Therapy +Targeted Low Dose chemotherapy has been taking advantage of the immune system cycle using it's regulatory mechanism by enhancing selectively the T cells in a cycle specific manner due to the actions of the insulin that acts as a modifier of the cell biologic response. Insulin enhances (potentiates) the anticancer effects of chemotherapy drugs.

Since Donato Perez Garcia,MD (1896-1971) the creator on this treatment for cancer and chronic degenerative diseases started to treat patients, he set the treatment appointments for every 7 days, this was back in the year 1930 for chronic degenerative diseases and in 1946 for cancer. He noted that patients had very good responses when they received their chemotherapy every 7 days. It was the time when observation and good clinical judgment played an important factor. His observations came to scientific support until the year 2009 when a team of Medical Doctors (Coventry, Ashdown, Quinn, Markovic, Yatomi-Clarke & Robinson) from Department of Surgery & Tumor Immunology Laboratory, University of Adelaide, Royal Adelaide Hospital, Adelaide South Australia identified the homeostatic immune oscillations in cancer patients that CR a protein indicated. This CRP is associated with inflammation and the activation of the immune system. (Journal of Translational Medicine 2009,7:102)

To my patients treated here in Tijuana, Baja California this means that they are receiving their chemotherapy protocol on the correct day, achieving the disruption of the regulatory circuits that protect the tumor cells. With my IPTLD protocol my patients are also taking advantage of the induced and controlled hyperthermia that insulin produces and it is well known that a high body temperature also helps in the fight against cancer.
I started to treat cancer and chronic degenerative disease patients back in 1983 and during these 28 years or clinical practice I have seen several cancer patients that were initially treated with standard chemotherapy, responded well but later developed a cancer recurrence. Several of these patients who developed a metastases or recurrence were told that they build chemo resistance. When I started to treat them using the low dose insulin that acts as a modifier of the cell biologic response with the same chemo drugs they received as their first treatment they all had a good response. No need to mention that the Greek test to detect chemotherapeutic drugs sensitivity was not available.

CONCLUSION: To over come resistance of chemotherapy drugs -when they stopped working- the pre-treatment administration of insulin as it is done on IPTLD, is the solution to enhance the effect of the chemotherapy drug, making the use of insulin an important one to deliver effectively your chemotherapy drug combination at the right time and day to match your immune system activity . If the problem of making the chemo drug effective is solved by the pre-treatment administration of insulin, the sensitivity test to different chemo agents may not be as necessary as you may think in order to treat metastases or recurrences, because when the drugs are given on the right time and day, the response is a success. I have seen this happen many times during my 28 years of clinical experience with IPTLD/IPT and no other IPT doctor can compete with my long clinical experience of doing IPT/IPTLD.